{"result": "(\"entity\"<|>HOSPITAL<|>ORGANIZATION<|>The hospital provides various formulations of amino acids to meet the nutritional needs of patients, particularly those with specific medical conditions.)\n##\n(\"entity\"<|>AMINO ACIDS<|>EVENT<|>Amino acids are essential nutrients that play a crucial role in protein synthesis and overall health, with specific formulations tailored for different clinical situations.)\n##\n(\"entity\"<|>GLUTAMINE<|>PERSON<|>Glutamine is an amino acid that serves as a precursor for nucleotides and is beneficial in patients experiencing metabolic stress.)\n##\n(\"entity\"<|>HISTIDINE<|>PERSON<|>Histidine is an amino acid that is controversially used in acute renal failure and is indicated in oligoanuric situations.)\n##\n(\"entity\"<|>ENCEPHALOPATHY<|>EVENT<|>Encephalopathy is a condition that can affect patients with liver issues, requiring specific amino acid formulations for treatment.)\n##\n(\"entity\"<|>PROTEIN REQUIREMENTS<|>EVENT<|>Protein requirements vary based on patient conditions, with specific guidelines for maintenance and various health issues.)\n##\n(\"entity\"<|>NITROGEN BALANCE<|>EVENT<|>Maintaining nitrogen balance is crucial for patient recovery, particularly in those with metabolic stress or specific health conditions.)\n##\n(\"relationship\"<|>HOSPITAL<|>AMINO ACIDS<|>The hospital provides amino acid formulations to meet the nutritional needs of patients<|>8)\n##\n(\"relationship\"<|>GLUTAMINE<|>AMINO ACIDS<|>Glutamine is a specific amino acid that is important for patients under metabolic stress<|>7)\n##\n(\"relationship\"<|>HISTIDINE<|>AMINO ACIDS<|>Histidine is an amino acid that is used in specific formulations for patients with renal issues<|>6)\n##\n(\"relationship\"<|>ENCEPHALOPATHY<|>HISTIDINE<|>Histidine is indicated for patients suffering from encephalopathy<|>5)\n##\n(\"relationship\"<|>PROTEIN REQUIREMENTS<|>HOSPITAL<|>The hospital's formulations are designed to meet the protein requirements of various patient categories<|>7)\n##\n(\"relationship\"<|>NITROGEN BALANCE<|>PROTEIN REQUIREMENTS<|>Maintaining nitrogen balance is essential for meeting protein requirements in patients<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: idos esenciales (valina, leucina, isoleucina, treonina, lisina, metionina, fenilalanina y triptófano) y no esenciales, aunque estos últimos pueden ser esenciales en determinadas circunstancias según edad, estrés y enfermedad subyacente (histidina en enfermos renales, histidina y cisteína en niños, taurina en neonatos y prematuros, arginina y glutamina en adultos con estrés metabólico). Aportan aproximadamente 4 Kcal/g de energía.\n---\nLos aportes proteicos deben constituir entre el 12-16% del aporte calórico total. No se debe administrar menos de 1 g/ Kg/ día de proteínas, ni se recomiendan aportes mayores a 2 g/Kg/día. El aporte proteico se expresa normalmente en gramos de nitrógeno (1 g de nitrógeno equivale a 6,25 g de proteínas, 1 g de aa equivale a 0,14 g de N). Los requerimientos de nitrógeno varían entre 0,24-0,32 g/Kg/día (1,5-2 g de aa/Kg/día) según grado de agresión.\n\n| Necesidades proteicas en adultos | g de proteínas/ Kg/ día |\n|----------------------------------|--------------------------|\n| Mantenimiento | 0,8-1 |\n| Pacientes catabólicos | 1-2 |\n| Insuficiencia Renal (IR) | 0,6-1 |\n| IR en diálisis | 1-1,5 |\n| IR con hemofiltración continua | 1,5-2,5 |\n| Insuficiencia hepática (IH) | |\n| IH sin encefalopatía | 1-1,5 |\n| IH con encefalopatía | 0,6-1 |\n| Obesos | |\n| Índice masa corporal: 30-40 Kg/ m2 | 2 g/Kg Peso ideal/día |\n| Índice masa corporal: mayor de 40 Kg/ m2 | 2,5 g/Kg Peso ideal/día |\n\nPara optimizar la utilización del nitrógeno proteico ha de asegurarse un aporte energético suficiente. La relación entre Kcal. no proteicas y g de N debe disminuir a medida que aumenta el grado de estrés (desde 150 en estrés leve a 80-120 en estrés grave)\n\n| Grado de estrés | Kcal. no proteicas/ g de N |\n|-----------------|----------------------------|\n| Estrés leve | 140-150 |\n| Estrés moderado | 120-140 |\n| Estrés grave | 90-120 |\n\nLas formulaciones estándar de aa tienen por objeto cubrir las necesidades proteicas y mantener el balance nitrogenado, pero existen formulaciones especiales en las que varía la proporción de determinados aa para adaptarse mejor a la situación clínica a la que van destinados. Así, las formulaciones bajas en aa ramificados y enriquecidas en alanina son especialmente apropiadas para prematuros y niños en general, enfermos sépticos o traumatismos, mientras que las suplementadas con histidina se utilizan en insuficiencia renal.\n---\nEn nuestro hospital disponemos de las siguientes formulaciones:\n\n- Soluciones de aa estándar (los que aproximan su formulación al patrón huevo), con una relación entre la cantidad total en gramos de aminoácidos esenciales y la cantidad de nitrógeno total aproximadamente de 3. Contienen alrededor del 40% de aminoácidos esenciales, 18-20% ramificados y 8-9% aromáticos. La relación metionina/cisteína es de 10:1 hasta 22:1.\n\n- Soluciones de aa enriquecidas con aa ramificados 34% y reducción de aa aromáticos y metionina, en una relación 37:1 (Fórmula F080, Patrón Fischer) para pacientes con encefalopatía hepática o riesgo evidente de desarrollarla.\n\n- Soluciones de aa enriquecidas con histidina. Su utilización es controvertida en pacientes con insuficiencia renal aguda y únicamente se indican en situación oligoanúrica.\n\nLa glutamina es precursor de los anillos púricos y pirimidínicos de los ácidos nucleicos y nucleótidos y de sustratos de células de rápida replicación y del sistema inmune, por lo que tiene efecto sobre la mucosa intestinal manteniendo la función de barrera. Parece beneficiosa en enfermos con estrés metabólico (sepsis, traumas graves, cirugía mayor, trasplante de precursores hematopoyéticos, grandes quemados, enfermedades inflamatorias intestinales, intestino corto, enteritis post-radiación y quimioterapia), aunque son necesarios más estudios para demostrar su eficacia.\n\nSe trata de un aminoácido inestable e insoluble por lo que debe formularse en forma de dipéptidos de L-alanil-L-glutamina. Las dos\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}